PrimeVigilance Ltd.

What PrimeVigilance Ltd. does

PrimeVigilance Ltd. is a privately held provider of pharmacovigilance and medical information services, founded in 2008 and headquartered in Guildford, United Kingdom. The company operates as a for-profit entity with a workforce of 501–1,000 employees, serving the regulated drug-safety, adverse-event monitoring, and medical information needs of pharmaceutical and biotechnology clients. The pharmacovigilance market in which it operates is projected to reach $17.41B by 2030, expanding at a 12.5% CAGR, providing structural tailwinds for incumbent scaled providers.

The supplied input does not disclose revenue, ownership structure, leadership composition, product platform details, pricing model, or customer roster. Specific information on technology architecture — whether the company operates a proprietary case-management platform, leverages third-party safety databases (e.g., ARISg, Oracle Argus), or offers differentiated software beyond outsourced services — is not present in the source material. Similarly, contract structure (FFS vs. FTE vs. milestone-based), average deal size, client retention metrics, and geographic delivery footprint were not provided.

A deeper diligence pass would be required before substantiating competitive positioning, unit economics, technology stack claims, or concentration risk. At minimum, the evidence supports characterization of PrimeVigilance as a mid-sized, established UK-headquartered pharmacovigilance services provider participating in a high-growth regulated-services market, with operational scale that places it among the larger dedicated pharmacovigilance specialists globally.

Name

PrimeVigilance Ltd.

Legal name

PrimeVigilance Ltd.

Website

https://primevigilance.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

501–1,000 employees

Short description

PrimeVigilance Ltd. is a privately held UK-headquartered pharmacovigilance and medical information services provider, founded in 2008 in Guildford, employing 501–1,000 staff to deliver drug-safety and adverse-event monitoring services to pharmaceutical clients.

Ownership category

akta.pro rank

Product category

Pharmacovigilance Services

NAICS

Other Scientific and Technical Consulting Services (54169)

SIC

Services-Misc Health & Allied Services, Nec (8090), Services-Health Services (8000)

akta.pro primary industry

Pharmacovigilance, Drug Safety & Risk Management FSP (HLAGAOAF)

akta.pro secondary industries

Pharmacovigilance Quality & Compliance (PV audits, QPPV support, PSMF) (HLAGAKAH), Patient Support Programs & Device/Vaccine Vigilance (PSP/PSUR support) (HLAGALAK)

Keywords

• Pharmacovigilance services
• Medical information services
• Drug safety monitoring
• Adverse event reporting
• Regulatory safety compliance

Headquarters

HQ city

Guildford

HQ country

United Kingdom

HQ region

Europe

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Core offering

PrimeVigilance Ltd. is a for-profit pharmacovigilance and medical information services company that supports pharmaceutical and biotechnology clients with drug safety monitoring and adverse event reporting across the product lifecycle. Founded in 2008 and headquartered in Guildford, United Kingdom, the firm operates with 501-1,000 employees.

Differentiator

Problem solved

Functional benefit

Products and services

• Pharmacovigilance Services Drug safety monitoring and adverse event reporting services provided to pharmaceutical and biotechnology companies to support regulatory safety compliance across the product lifecycle.
• Medical Information Services Medical information services delivered to pharmaceutical and biotechnology clients, addressing healthcare professional and patient inquiries related to product safety and use.

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Scale indicators2 records

Direct peers

• Ergomed plc: Ergomed is the parent company that acquired PrimeVigilance in 2017 and continues to operate the brand. It is the closest comparable as the PV services business is consolidated under Ergomed's Clinical and PV Safety reporting segment, sharing resources and customers.
• Worldwide Clinical Trials: Worldwide Clinical Trials is a mid-sized global CRO with a dedicated pharmacovigilance and medical affairs practice, closely comparable to PrimeVigilance in scale and service mix.
• Arriello: Arriello is a specialist pharmacovigilance, regulatory affairs, and quality consultancy serving pharma and biotech. As a PV-focused European firm, it is one of the most direct specialist peers to PrimeVigilance.
• PharmaLex (now part of Cencora): PharmaLex is a specialist regulatory, pharmacovigilance, and quality consulting firm recently acquired by Cencora, providing comparable PV, QPPV, and GxP services to mid-sized pharma sponsors.
• ProPharma Group: ProPharma Group provides pharmacovigilance, regulatory compliance, and medical information services to pharma and medical device companies, directly comparable in service offering and customer base.
• Clinipace Worldwide: Clinipace is a mid-sized CRO offering clinical, biostatistics, and pharmacovigilance services with a similar sponsor base of small-to-mid biopharma customers.

Broad incumbents

• IQVIA: IQVIA is the largest global CRO with a substantial pharmacovigilance and safety services practice. It competes with PrimeVigilance for enterprise-level PV outsourcing contracts across large pharma sponsors.
• ICON plc: ICON offers broad CRO services including dedicated pharmacovigilance, drug safety, and medical information teams. It is a top-tier competitor for full-service and FSP-style PV engagements.
• Parexel International: Parexel is a major global CRO with deep pharmacovigilance, regulatory affairs, and medical affairs offerings, directly competing with PrimeVigilance for safety outsourcing work.
• Syneos Health: Syneos Health provides clinical and commercial services including pharmacovigilance and drug safety operations, representing a broad incumbent peer for PrimeVigilance's core offerings.

Market position

Strengths3 records

Weaknesses4 records

Competitive moat3 records

Key risks5 records

Key highlights5 records

Customer concentration

• Xx.com/primevigilance
• LinkedInlinkedin.com/company/primevigilance-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about PrimeVigilance Ltd.